Clinical trial
Early Combined Use of Inhaled Nitric Oxide and Oral Sildenafil on the Outcome of Pulmonary Hypertension in New Born Infants
NCT01558466 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Combined Use of Inhaled Nitric Oxide and Oral Sildenafil on the Outcome of Pulmonary Hypertension in New Born Infants
- Lead sponsor
- Hamad Medical Corporation
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- November 30, 2011
- Completion date
- June 30, 2015
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.